These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 7538087)

  • 1. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
    Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
    Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects.
    Schatz DA; Lang F; Cantor AB; Riley WJ; Maclaren NK; Sleasman JW; Barrett DJ
    Diabetes; 1991 Oct; 40(10):1314-8. PubMed ID: 1718800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin.
    Casali P; Nakamura M; Ginsberg-Fellner F; Notkins AL
    J Immunol; 1990 May; 144(10):3741-7. PubMed ID: 2159034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal type lymphocytes in insulin dependent diabetes mellitus.
    Gyarmati J; Szekeres-Barthó J; Fischer B; Soltész G
    Autoimmunity; 1999; 30(2):63-9. PubMed ID: 10435718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children.
    Gerling I; Baekkeskov S; Lernmark A
    J Immunol; 1986 Dec; 137(12):3782-5. PubMed ID: 3537124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.
    Kasaian MT; Ikematsu H; Casali P
    J Immunol; 1992 May; 148(9):2690-702. PubMed ID: 1374094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients.
    Nicoletti F; Meroni PL; Barcellini W; Steinsväg PO; Di Mauro M; Lunetta M; Pagano M; Consoli U; Zanussi C
    Immunol Lett; 1990 Jan; 23(3):211-5. PubMed ID: 1689697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
    Houssaint E; Pogu S; Ouary M; Sai P
    Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients.
    Burastero SE; Cutolo M; Dessì V; Celada F
    Scand J Immunol; 1990 Oct; 32(4):347-57. PubMed ID: 1700467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients.
    Nicoletti F; Scalia G; Lunetta M; Condorelli F; Di Mauro M; Barcellini W; Stracuzzi S; Pagano M; Meroni PL
    Clin Immunol Immunopathol; 1990 Apr; 55(1):139-47. PubMed ID: 2155076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus.
    Nakamura M; Burastero SE; Ueki Y; Larrick JW; Notkins AL; Casali P
    J Immunol; 1988 Dec; 141(12):4165-72. PubMed ID: 2848890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies in children with type I diabetes mellitus and their healthy relatives: in vitro antigen stimulated IgM production, T-cell subsets and islet-cell antibodies.
    Etzioni A; Vardi P; Benderly A; Katz R; Pollack S
    J Clin Lab Immunol; 1987 Dec; 24(4):163-6. PubMed ID: 3329227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.
    Mantovani L; Wilder RL; Casali P
    J Immunol; 1993 Jul; 151(1):473-88. PubMed ID: 7686945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ; Honeyman MC; Harrison LC
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition.
    Kasaian MT; Casali P
    Autoimmunity; 1993; 15(4):315-29. PubMed ID: 7511005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.